Radiotherapy in combination with immune checkpoint inhibitors

Dirk De Ruysscher; Kobe Reynders; Evert Van Limbergen; Maarten Lambrecht

doi:10.1097/CCO.0000000000000352

Radiotherapy in combination with immune checkpoint inhibitors

Dirk De Ruysscher^*, Kobe Reynders, Evert Van Limbergen, Maarten Lambrecht

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	105-111
Number of pages	7
Journal	Current Opinion in Oncology
Volume	29
Issue number	2
DOIs	https://doi.org/10.1097/CCO.0000000000000352
Publication status	Published - Mar 2017

Keywords

cancer
checkpoint inhibitors
immune therapy
radiation
radiotherapy
CELL LUNG-CANCER
IMMUNOTHERAPY
IRRADIATION
DOCETAXEL
PEMBROLIZUMAB
MULTICENTER
IPILIMUMAB
NIVOLUMAB
RADIATION
MICE

Access to Document

10.1097/CCO.0000000000000352

Cite this

De Ruysscher, D., Reynders, K., Van Limbergen, E., & Lambrecht, M. (2017). Radiotherapy in combination with immune checkpoint inhibitors. Current Opinion in Oncology, 29(2), 105-111. https://doi.org/10.1097/CCO.0000000000000352

@article{c6f4e193bc5f46a4b7641a976fe524f7,

title = "Radiotherapy in combination with immune checkpoint inhibitors",

keywords = "cancer, checkpoint inhibitors, immune therapy, radiation, radiotherapy, CELL LUNG-CANCER, IMMUNOTHERAPY, IRRADIATION, DOCETAXEL, PEMBROLIZUMAB, MULTICENTER, IPILIMUMAB, NIVOLUMAB, RADIATION, MICE",

author = "{De Ruysscher}, Dirk and Kobe Reynders and {Van Limbergen}, Evert and Maarten Lambrecht",

year = "2017",

month = mar,

doi = "10.1097/CCO.0000000000000352",

language = "English",

volume = "29",

pages = "105--111",

journal = "Current Opinion in Oncology",

issn = "1040-8746",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "2",

}

TY - JOUR

T1 - Radiotherapy in combination with immune checkpoint inhibitors

AU - De Ruysscher, Dirk

AU - Reynders, Kobe

AU - Van Limbergen, Evert

AU - Lambrecht, Maarten

PY - 2017/3

Y1 - 2017/3

KW - cancer

KW - checkpoint inhibitors

KW - immune therapy

KW - radiation

KW - radiotherapy

KW - CELL LUNG-CANCER

KW - IMMUNOTHERAPY

KW - IRRADIATION

KW - DOCETAXEL

KW - PEMBROLIZUMAB

KW - MULTICENTER

KW - IPILIMUMAB

KW - NIVOLUMAB

KW - RADIATION

KW - MICE

U2 - 10.1097/CCO.0000000000000352

DO - 10.1097/CCO.0000000000000352

M3 - Review article

VL - 29

SP - 105

EP - 111

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 2

ER -